The fourth Machine Learning for Health (ML4H) symposium was held in person on December 15th and 16th, 2024, in the traditional, ancestral, and unceded territories of the Musqueam, Squamish, and Tsleil-Waututh Nations in Vancouver, British Columbia, Canada. The symposium included research roundtable sessions to foster discussions between participants and senior researchers on timely and relevant topics for the ML4H community. The organization of the research roundtables at the conference involved 13 senior and 27 junior chairs across 13 tables. Each roundtable session included an invited senior chair (with substantial experience in the field), junior chairs (responsible for facilitating the discussion), and attendees from diverse backgrounds with an interest in the session's topic.

In the aftermath of the COVID-19 pandemic and amid accelerating climate change, emerging infectious diseases, particularly those arising from zoonotic spillover, remain a global threat. Mpox (caused by the monkeypox virus) is a notable example of a zoonotic infection that often goes undiagnosed, especially as its rash progresses through stages, complicating detection across diverse populations with different presentations. In August 2024, the WHO Director-General declared the mpox outbreak a public health emergency of international concern for a second time. Despite the deployment of deep learning techniques for detecting diseases from skin lesion images, a robust and publicly accessible foundation model for mpox diagnosis is still lacking due to the unavailability of open-source mpox skin lesion images, multimodal clinical data, and specialized training pipelines. To address this gap, we propose MpoxVLM, a vision-language model (VLM) designed to detect mpox by analyzing both skin lesion images and patient clinical information. MpoxVLM integrates the CLIP visual encoder, an enhanced Vision Transformer (ViT) classifier for skin lesions, and LLaMA-2-7B models, pre-trained and fine-tuned on visual instruction-following question-answer pairs from our newly released mpox skin lesion dataset. Our work achieves 90.38% accuracy for mpox detection, offering a promising pathway to improve early diagnostic accuracy in combating mpox.

Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder with very high prevalence around the world. Research progress in the field of ASD facial analysis in pediatric patients has been hindered due to a lack of well-established baselines. In this paper, we propose the use of the Vision Transformer (ViT) for the computational analysis of pediatric ASD. The presented model, known as ViTASD, distills knowledge from large facial expression datasets and offers model structure transferability. Specifically, ViTASD employs a vanilla ViT to extract features from patients' face images and adopts a lightweight decoder with a Gaussian Process layer to enhance the robustness for ASD analysis. Extensive experiments conducted on standard ASD facial analysis benchmarks show that our method outperforms all of the representative approaches in ASD facial analysis, while the ViTASD-L achieves a new state-of-the-art. Our code and pretrained models are available at https://github.com/IrohXu/ViTASD.